| |
 |
Editorial [Hot Topic: ADAMs: Targets for Drug Discovery (Executive Editor: Marcia L. Moss)]
|
| |
|
pp.2270-2271 (2) Author: Marcia L. Moss
|
| |
|
|
| |
|
ADAM8/MS2/CD156, an Emerging Drug Target in the Treatment of Inflammatory and Invasive Pathologies
|
| |
|
pp.2272-2281 (10) Authors: Garrit Koller, Uwe Schlomann, Panagiota Golfi, Taheera Ferdous, Silvia Naus, Jorg W. Bartsch
|
| |
|
|
| |
|
ADAM9 as a Potential Target Molecule in Cancer
|
| |
|
pp.2282-2287 (6) Author: Lucie Peduto
|
| |
|
|
| |
|
ADAM10 as a Therapeutic Target for Cancer and Inflammation
|
| |
|
pp.2288-2299 (12) Authors: Howard C. Crawford, Peter J. Dempsey, Gordon Brown, Liana Adam, Marcia L. Moss
|
| |
|
|
| |
|
Targeting ADAM12 in Human Disease: Head, Body or Tail?
|
| |
|
pp.2300-2310 (11) Authors: J. Jacobsen, U. M. Wewer
|
| |
|
|
| |
|
The Therapeutic Potential of ADAM15
|
| |
|
pp.2311-2318 (8) Authors: Neali Lucas, Abdo J. Najy, Mark L. Day
|
| |
|
|
| |
|
ADAM17 as a Therapeutic Target in Multiple Diseases
|
| |
|
pp.2319-2335 (17) Authors: Joaquin Arribas, Cary Esselens
|
| |
|
|
| |
|
ADAM19/Adamalysin 19 Structure, Function, and Role as a Putative Target in Tumors and Inflammatory Diseases
|
| |
|
pp.2336-2348 (13) Authors: Bin Qi, Robert G. Newcomer, Qing-Xiang Amy Sang
|
| |
|
|
| |
|
ADAM28 as a Target for Human Cancers
|
| |
|
pp.2349-2358 (10) Authors: Satsuki Mochizuki, Yasunori Okada
|
| |
|
|
| |
|
A Review of the ADAMTS Family, Pharmaceutical Targets of the Future
|
| |
|
pp.2359-2374 (16) Authors: Micky D. Tortorella, Fransiska Malfait, Ruteja A Barve, Huey-Sheng Shieh, Anne-Marie Malfait
|
| |
|
|
